Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Le An

Showing results (121-130 of 130) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 130 results.
Environmental Research|June 12, 2025
Assessing personal PM<sub>2.5</sub> exposure from various microenvironments among schoolchildren in VietnamNguyen Thi Tuong Vy, Hong H T C Le, Pham Le An, et al.
The Lancet. Global Health|December 17, 2021
Mapping low-resource contexts to prepare for lung health interventions in four countries (FRESH AIR): a mixed-method studyEvelyn A Brakema, Rianne M J J van der Kleij, Charlotte C Poot, et al.
ACS Medicinal Chemistry Letters|March 19, 2020
Discovery of Potent Benzolactam IRAK4 Inhibitors with Robust in Vivo ActivityNaomi S Rajapaksa, Alberto Gobbi, Joy Drobnick, et al.
Journal of Medicinal Chemistry|May 15, 2019
Development of Potent and Selective Pyrazolopyrimidine IRAK4 InhibitorsMarian C Bryan, Joy Drobnick, Alberto Gobbi, et al.
Bioorganic & Medicinal Chemistry Letters|May 18, 2017
From a novel HTS hit to potent, selective, and orally bioavailable KDM5 inhibitorsJun Liang, Sharada Labadie, Birong Zhang, et al.
ACS Medicinal Chemistry Letters|January 21, 2022
Discovery of Spiro-azaindoline Inhibitors of Hematopoietic Progenitor Kinase 1 (HPK1)Bryan K Chan, Eileen Seward, Michael Lainchbury, et al.
ACS Medicinal Chemistry Letters|September 18, 2024
Discovery of GNE-6893, a Potent, Selective, Orally Bioavailable Small Molecule Inhibitor of HPK1John C Tellis, BinQing Wei, Michael Siu, et al.
Nature Cancer|June 5, 2023
An allosteric pan-TEAD inhibitor blocks oncogenic YAP/TAZ signaling and overcomes KRAS G12C inhibitor resistanceThijs J Hagenbeek, Jason R Zbieg, Marc Hafner, et al.
Journal of Medicinal Chemistry|September 12, 2017
GNE-781, A Highly Advanced Potent and Selective Bromodomain Inhibitor of Cyclic Adenosine Monophosphate Response Element Binding Protein, Binding Protein (CBP)F Anthony Romero, Jeremy Murray, Kwong Wah Lai, et al.
Nature Communications|June 27, 2026
Covalent pan-TEAD inhibitors block YAP activity and demonstrate brain penetrance in a Hippo-dependent cancer modelThijs J Hagenbeek, Jason Zbieg, Russell Smith, et al.
Pageof 13

Showing results (121-130 of 130) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 130 results.
Environmental Research|June 12, 2025
Assessing personal PM<sub>2.5</sub> exposure from various microenvironments among schoolchildren in VietnamNguyen Thi Tuong Vy, Hong H T C Le, Pham Le An, et al.
The Lancet. Global Health|December 17, 2021
Mapping low-resource contexts to prepare for lung health interventions in four countries (FRESH AIR): a mixed-method studyEvelyn A Brakema, Rianne M J J van der Kleij, Charlotte C Poot, et al.
ACS Medicinal Chemistry Letters|March 19, 2020
Discovery of Potent Benzolactam IRAK4 Inhibitors with Robust in Vivo ActivityNaomi S Rajapaksa, Alberto Gobbi, Joy Drobnick, et al.
Journal of Medicinal Chemistry|May 15, 2019
Development of Potent and Selective Pyrazolopyrimidine IRAK4 InhibitorsMarian C Bryan, Joy Drobnick, Alberto Gobbi, et al.
Bioorganic & Medicinal Chemistry Letters|May 18, 2017
From a novel HTS hit to potent, selective, and orally bioavailable KDM5 inhibitorsJun Liang, Sharada Labadie, Birong Zhang, et al.
ACS Medicinal Chemistry Letters|January 21, 2022
Discovery of Spiro-azaindoline Inhibitors of Hematopoietic Progenitor Kinase 1 (HPK1)Bryan K Chan, Eileen Seward, Michael Lainchbury, et al.
ACS Medicinal Chemistry Letters|September 18, 2024
Discovery of GNE-6893, a Potent, Selective, Orally Bioavailable Small Molecule Inhibitor of HPK1John C Tellis, BinQing Wei, Michael Siu, et al.
Nature Cancer|June 5, 2023
An allosteric pan-TEAD inhibitor blocks oncogenic YAP/TAZ signaling and overcomes KRAS G12C inhibitor resistanceThijs J Hagenbeek, Jason R Zbieg, Marc Hafner, et al.
Journal of Medicinal Chemistry|September 12, 2017
GNE-781, A Highly Advanced Potent and Selective Bromodomain Inhibitor of Cyclic Adenosine Monophosphate Response Element Binding Protein, Binding Protein (CBP)F Anthony Romero, Jeremy Murray, Kwong Wah Lai, et al.
Nature Communications|June 27, 2026
Covalent pan-TEAD inhibitors block YAP activity and demonstrate brain penetrance in a Hippo-dependent cancer modelThijs J Hagenbeek, Jason Zbieg, Russell Smith, et al.
Pageof 13